fbpx Skip to main content

MONDAY, Feb. 1, 2021 (HealthDay News) — Women with premature ovarian insufficiency (POI) experience a high prevalence of menopausal symptoms, according to a study published online Jan. 18 in Menopause.

Yizhou Huang, M.D., from the Zhejiang University School of Medicine in Hangzhou, China, and colleagues evaluated the prevalence, severity, and associated factors of menopausal symptoms in women with POI. The analysis included 293 women seen at an outpatient clinic.

The researchers found that the most prevalent symptoms were mood swings (73.4 percent), insomnia (58.7 percent), sexual problems (58.7 percent), and fatigue (57.3 percent). Among the most frequently reported symptoms were moderate-to-severe mood swings (23.9 percent), formication (17.4 percent), and hot flashes/sweating (17.1 percent). Women with POI exhibited significantly higher risks for fatigue (odds ratio [OR], 1.42), melancholia (OR, 3.12), mood swings (OR, 3.57), and insomnia (OR, 1.41) compared with women with natural menopause. Additionally, women with POI had significantly lower risks for moderate-to-severe sexual problems (0.40) and any and moderate-to-severe muscle or joint pain (OR, 0.41 and 0.45, respectively). There was an independent association between living in urban areas and higher gravidity with menopausal symptoms in women with POI.

“Women with POI tended to have more distressing menopausal symptoms compared with women with natural menopause,” the authors write.

Abstract/Full Text (subscription or payment may be required)

You May Also Like::  Fear of Surprise Medical Bills Keeps U.S. Adults From Getting Care

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.

#dermtwitter
@AADmember

New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More